Nicholas Galakatos, 10% Owner at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 5,193,960 shares at $4.49 ($26.3M) on 2010-11-02, disclosed to the SEC on 2010-11-02.
Open-market sale of $26.3M AVNR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.06 | 1,424,947 | $7.2M | 27.4% |
| 2 | $5.36 | 2,478,142 | $13.3M | 50.5% |
| 3 | $4.49 | 1,290,871 | $5.8M | 22.0% |
| Total | $5.06 avg | 5,193,960 | $26.3M | 100% |
| Filing → |
| FTSV | BUY | 2018-07-02 | $3.2M | — | Filing → |
| OPHT | SELL | 2016-01-13 | $197K | — | Filing → |
| OPHT | SELL | 2015-12-14 | $193K | — | Filing → |